Literature DB >> 9854680

The modulation of glucocorticoid receptor content by 3-O-methyl-D-glucose transport in human mononuclear leukocyte in obesity.

M Güven1, H Hatemi, E Taşan, Y Altuntaş, T Ulutin, V Tezcan, G Kanigür-Sultuybek.   

Abstract

Glucocorticoid receptors (GR) and 3-O-methyl-D glucose (3-O-MG) transport were determined in mononuclear leukocytes (MNL) from 11 abdominal obese subjects, 10 pituitary-dependent Cushing's syndrome (Cushing's disease) and 10 healthy controls. Using a whole-cell competitive binding assay and 3H-dexamethasone as tracer, MNL of abdominal obese subjects were found to have 4855 +/- 1389 sites/cell which was significantly lower (p < 0.05) than controls (6234 +/- 1568 sites/cell), although no significant difference was found in the mean serum cortisol level. Their mean Kd (affinity) was also significantly lower than that found in the healthy controls (obese Kd:2.92 +/- 0.84 nmol/l, control Kd: 4.55 +/- 0.67 nM, p < 0.05). On the other hand, the receptor characteristics in Cushing's disease patients were within the normal range. At the same time, 3-O-MG transport was determined in the same subjects. In Cushing's disease, 3-O-MG transport was within the normal range, whereas in abdominal obesity this value was significantly lower than the healthy controls (abdominal obese: 31.90 +/- 8.20; control: 46.26 +/- 12.91 fmol/10(6) cell, min, p < 0.05). We also found a positive correlation between 3-O-MG transport and GR binding capacity in abdominal subjects (r = 0.89, p < 0.001), however we did not find such a correlation in Cushing's disease (r = 0.60, p > 0.05). These results indicated that, in abdominal obesity, the GR binding capacity in MNL is influenced by the changes in glucose transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9854680     DOI: 10.1007/BF03350794

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Fat distribution and body weight.

Authors:  G A Bray
Journal:  Obes Res       Date:  1993-05

Review 2.  Cellular insulin action and insulin resistance.

Authors:  W T Garvey; M J Birnbaum
Journal:  Baillieres Clin Endocrinol Metab       Date:  1993-10

Review 3.  Cushing's syndrome.

Authors:  T A Howlett; L H Rees; G M Besser
Journal:  Clin Endocrinol Metab       Date:  1985-11

4.  Regulation of glucocorticoid receptors in human mononuclear cells: effects of glucocorticoid treatment, Cushing's disease and ketoconazole.

Authors:  E Pardes; J E De Yampey; D F Moses; A F De Nicola
Journal:  J Steroid Biochem Mol Biol       Date:  1991-08       Impact factor: 4.292

5.  Glucocorticoid receptor and inhibition of 3-O-methyl-D-glucose uptake by glucocorticoids in peripheral blood leukocytes from normal humans: correlation between receptor level and hormone effect in vitro.

Authors:  H Tanaka; H Akama; Y Ichikawa; M Homma; I Makino
Journal:  Acta Endocrinol (Copenh)       Date:  1992-01

6.  Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects.

Authors:  D Daneman; B Zinman; M E Elliott; P J Bilan; A Klip
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

7.  Glucocorticoid receptors in normal leukocytes: effects of age, gender, season, and plasma cortisol concentrations.

Authors:  H Tanaka; H Akama; Y Ichikawa; M Homma; H Oshima
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

8.  Glucocorticoid receptors in monocytes in type 1 diabetes mellitus.

Authors:  P Damm; C Binder
Journal:  Clin Chim Acta       Date:  1989-09-29       Impact factor: 3.786

Review 9.  Hormones and obesity.

Authors:  P G Kopelman
Journal:  Baillieres Clin Endocrinol Metab       Date:  1994-07

10.  Regulation of the glucocorticoid receptor by glucocorticoids in human mononuclear leukocytes.

Authors:  M M Brentani; B L Wajchenberg; F P Cesar; V R Martins
Journal:  Horm Res       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.